# EDGAR Filing Document

**Accession Number:** 0001281895
**File Stem:** 0001140361-26-008290
**Filing Date:** 2026-3
**Character Count:** 2399
**Document Hash:** 308014ada48a22564fa02b5f1af72a80
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-26-008290.hdr.sgml**: 20260407

**ACCESSION NUMBER**: 0001140361-26-008290

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260306

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ROCKET PHARMACEUTICALS, INC.
- **CENTRAL INDEX KEY:** 0001281895
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 350 FIFTH AVENUE
- **STREET 2:** SUITE 7530
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10118
- **BUSINESS PHONE:** 646-440-9100

**MAIL ADDRESS:**
- **STREET 1:** 350 FIFTH AVENUE
- **STREET 2:** SUITE 7530
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10118

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INOTEK PHARMACEUTICALS CORP
- **DATE OF NAME CHANGE:** 20040226

![](ny20066752x2_logo.jpg)

March 6, 2026

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, D.C. 20549

Attn: Alan Campbell

**Re: Acceleration Request for Rocket Pharmaceuticals, Inc. Registration Statement on Form S-3 (File No. 333-293925)**

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Rocket Pharmaceuticals, Inc. (the "Company") hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Washington, D.C. time, on March 10, 2026 or as soon thereafter as is practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff.

It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Sean Jones of K&L Gates LLP, our counsel, at (704) 331-7406. We appreciate your assistance in this matter.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **Rocket Pharmaceuticals, Inc.** | **Rocket Pharmaceuticals, Inc.** |
| By:&nbsp;&nbsp;&nbsp;&nbsp;  | /s/ Martin Wilson  |
| Name: Martin Wilson | Name: Martin Wilson |
| Title: General Counsel and Chief Corporate Officer | Title: General Counsel and Chief Corporate Officer |

---

------

#### <br>

<br>